Text Size

Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

This study is currently recruiting participants.
Verified March 2013 by University of Alabama at Birmingham
Sponsor:
Information provided by (Responsible Party):
Charles Mel Wilcox, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00609726
First received: January 24, 2008
Last updated: March 13, 2013
Last verified: March 2013
History of Changes
  Purpose

The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.


Condition
Gallbladder Disease
Pancreatitis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • Evaluation of current clinical practice for patients with idiopathic pancreatitis [ Time Frame: 3 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: October 2004
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Detailed Description:

The study evaluates the role of endoscopic ultrasonography, given that the minimally invasive procedures can diagnosis gallbladder disease as well as pancreatitis abnormalities.

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Men and women diagnosed with unexplained pancreatitis.

Criteria

Inclusion Criteria:

  • All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.

Exclusion Criteria:

  • There are no gender nor racial exclusion.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00609726

Contacts
Contact: Charles M Wilcox, M.D. 205-975-4958

Locations
United States, Alabama
University of Alabama Recruiting
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
Charles Mel Wilcox, MD
Investigators
Principal Investigator: Charles M Wilcox, M.D. University of Alabama at Birmingham
  More Information

No publications provided

Responsible Party: Charles Mel Wilcox, MD, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT00609726     History of Changes
Other Study ID Numbers: X040909004, 228552
Study First Received: January 24, 2008
Last Updated: March 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
Endoscopic Ultrasonography
Pancreatitis
EUS

Additional relevant MeSH terms:
Gallbladder Diseases
Pancreatitis
Biliary Tract Diseases
Digestive System Diseases
Pancreatic Diseases

ClinicalTrials.gov processed this record on June 13, 2013